Stay updated with breaking news from Adxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research report on Thursday, November 16th. Get Our Latest Stock Analysis on […]
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Tuesday. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reiterated a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. View Our Latest Analysis on Ayala […]
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. View Our Latest Research Report on ADXS […]
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reissued a neutral rating on shares of Ayala Pharmaceuticals in a report on Thursday, November 16th. View Our Latest Analysis on Ayala […]
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reissued a neutral rating on shares of Ayala Pharmaceuticals in a report on Thursday, November 16th. View Our Latest Research […]